IgA-话题@MedSci

#IgA#

129篇内容 | 3262人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1503988, encodeId=013f150398831, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=J Am Acad Dermatol：Omiganan可有效恢复轻中度特应性皮炎患者失调的菌群，但是不能改善患者的临床症状, objectType=article, longId=726573, objectId=2e80e2657345, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e80e2657345, replyNumber=0, likeNumber=85, createdTime=2022-05-12, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e80e2657345, moduleTitle=J Am Acad Dermatol：Omiganan可有效恢复轻中度特应性皮炎患者失调的菌群，但是不能改善患者的临床症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e80e2657345)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503986, encodeId=7469150398645, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=阿斯利康表示Farxiga达到了III期心力衰竭研究的主要终点, objectType=article, longId=726470, objectId=5a4ce2647008, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a4ce2647008, replyNumber=0, likeNumber=0, createdTime=2022-05-11, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a4ce2647008, moduleTitle=阿斯利康表示Farxiga达到了III期心力衰竭研究的主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a4ce2647008)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503985, encodeId=e8ca150398593, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=FDA批准Igalmi治疗精神分裂症或双相障碍, objectType=article, longId=723944, objectId=b606e23944ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b606e23944ae, replyNumber=0, likeNumber=84, createdTime=2022-04-12, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b606e23944ae, moduleTitle=FDA批准Igalmi治疗精神分裂症或双相障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b606e23944ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503984, encodeId=5f591503984fb, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=Kidney Int Rep：南亚前瞻性纵向观察IgA肾病队列的三年临床结果, objectType=article, longId=301120, objectId=63b6301120e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63b6301120e5, replyNumber=0, likeNumber=88, createdTime=2022-03-20, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63b6301120e5, moduleTitle=Kidney Int Rep：南亚前瞻性纵向观察IgA肾病队列的三年临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63b6301120e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503983, encodeId=838c15039836f, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=Front Med：C4d是狼疮性肾炎和IgA肾病临床结果的筛选工具和独立预测因子。, objectType=article, longId=301118, objectId=21c1301118dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21c1301118dd, replyNumber=0, likeNumber=90, createdTime=2022-03-20, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21c1301118dd, moduleTitle=Front Med：C4d是狼疮性肾炎和IgA肾病临床结果的筛选工具和独立预测因子。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21c1301118dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503982, encodeId=4893150398213, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=20年来首个慢性肾脏病治疗药物Forxiga获得NICE推荐, objectType=article, longId=295124, objectId=7b19295124e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b19295124e8, replyNumber=0, likeNumber=0, createdTime=2022-02-06, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b19295124e8, moduleTitle=20年来首个慢性肾脏病治疗药物Forxiga获得NICE推荐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b19295124e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503981, encodeId=2abf150398158, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=Front Immunol:313例捷克IgA肾病患者肾移植后的转归, objectType=article, longId=294958, objectId=1ab4294958bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ab4294958bf, replyNumber=0, likeNumber=82, createdTime=2022-02-01, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ab4294958bf, moduleTitle=Front Immunol:313例捷克IgA肾病患者肾移植后的转归, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ab4294958bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503980, encodeId=2351150398047, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=Front Immunol：IgA肾病风险预测模型比较的验证研究, objectType=article, longId=294957, objectId=f20729495e98, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f20729495e98, replyNumber=0, likeNumber=0, createdTime=2022-02-01, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f20729495e98, moduleTitle=Front Immunol：IgA肾病风险预测模型比较的验证研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f20729495e98)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503979, encodeId=dff915039e95b, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=Front Immunol：高中性粒细胞与淋巴细胞比值是终末期IgA肾病的独立危险因素, objectType=article, longId=294589, objectId=fc272945897b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc272945897b, replyNumber=0, likeNumber=83, createdTime=2022-01-25, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc272945897b, moduleTitle=Front Immunol：高中性粒细胞与淋巴细胞比值是终末期IgA肾病的独立危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc272945897b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503978, encodeId=ad1115039e852, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=EBioMedicine：红细胞增多与IgA肾病有关, objectType=article, longId=294147, objectId=022329414ebe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=022329414ebe, replyNumber=0, likeNumber=63, createdTime=2022-01-19, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=022329414ebe, moduleTitle=EBioMedicine：红细胞增多与IgA肾病有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=022329414ebe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503977, encodeId=ff1d15039e764, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=Front Immunol：尿可溶性CD163水平可以预测IgA肾病缓解状态, objectType=article, longId=294146, objectId=88c529414628, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88c529414628, replyNumber=0, likeNumber=61, createdTime=2022-01-19, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88c529414628, moduleTitle=Front Immunol：尿可溶性CD163水平可以预测IgA肾病缓解状态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88c529414628)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503976, encodeId=0f6115039e624, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=Sci Rep：静脉冲击注射甲基强的松龙联合小剂量强的松治疗高危IgA肾病, objectType=article, longId=294092, objectId=604929409250, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=604929409250, replyNumber=0, likeNumber=85, createdTime=2022-01-18, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=604929409250, moduleTitle=Sci Rep：静脉冲击注射甲基强的松龙联合小剂量强的松治疗高危IgA肾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=604929409250)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503975, encodeId=e7a315039e528, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=因为知情同意不完善导致文章撤稿：老年肺转移腺癌患者的副肿瘤性IgA血管炎, objectType=article, longId=292754, objectId=2f37292e548b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f37292e548b, replyNumber=0, likeNumber=76, createdTime=2021-12-27, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f37292e548b, moduleTitle=因为知情同意不完善导致文章撤稿：老年肺转移腺癌患者的副肿瘤性IgA血管炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f37292e548b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503974, encodeId=5e2715039e464, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=KIDNEY INT REP：牛津分类法在IgA肾病类固醇治疗中的应用, objectType=article, longId=219057, objectId=849021905e56, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=849021905e56, replyNumber=0, likeNumber=123, createdTime=2021-10-24, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=849021905e56, moduleTitle=KIDNEY INT REP：牛津分类法在IgA肾病类固醇治疗中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=849021905e56)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503973, encodeId=72dd15039e3f6, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=J Thorac Oncol：Brigatinib（布加替尼）vs Crizotinib（克唑替尼）治疗未治ALK阳性晚期非小细胞肺癌患者的疗效：3期临床研究ALTA-1L最终分析结果, objectType=article, longId=217316, objectId=e44421e31653, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e44421e31653, replyNumber=0, likeNumber=38, createdTime=2021-09-20, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e44421e31653, moduleTitle=J Thorac Oncol：Brigatinib（布加替尼）vs Crizotinib（克唑替尼）治疗未治ALK阳性晚期非小细胞肺癌患者的疗效：3期临床研究ALTA-1L最终分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e44421e31653)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503972, encodeId=71b715039e2a5, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=NEJM: 李勇教授团队：FIGARO为糖尿病患者保肾护心再添利器, objectType=article, longId=216473, objectId=2d182164e309, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d182164e309, replyNumber=0, likeNumber=95, createdTime=2021-09-01, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d182164e309, moduleTitle=NEJM: 李勇教授团队：FIGARO为糖尿病患者保肾护心再添利器, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d182164e309)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503971, encodeId=a32215039e11e, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=Clin J Am Soc Nephrol：成人肾移植术后IgA肾病的复发情况如何？, objectType=article, longId=216122, objectId=c8e321612251, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8e321612251, replyNumber=0, likeNumber=71, createdTime=2021-08-23, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8e321612251, moduleTitle=Clin J Am Soc Nephrol：成人肾移植术后IgA肾病的复发情况如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8e321612251)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503970, encodeId=1cba15039e01e, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=SGLT2抑制剂Forxiga获得欧盟和英国的批准，用于治疗慢性肾病, objectType=article, longId=215519, objectId=1da5215519ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1da5215519ba, replyNumber=0, likeNumber=61, createdTime=2021-08-11, rootId=0, userName=yibei, userId=c23f9697922, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1da5215519ba, moduleTitle=SGLT2抑制剂Forxiga获得欧盟和英国的批准，用于治疗慢性肾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1da5215519ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503969, encodeId=d102150396951, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=American Journal of Clinical Nutrition:益生菌治疗无法增加大便sIgA浓度, objectType=article, longId=214976, objectId=d5152149e6bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5152149e6bb, replyNumber=0, likeNumber=71, createdTime=2021-07-30, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5152149e6bb, moduleTitle=American Journal of Clinical Nutrition:益生菌治疗无法增加大便sIgA浓度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5152149e6bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1503968, encodeId=04c815039687d, content=<a href='/topic/show?id=641d94e7eb' target=_blank style='color:#2F92EE;'>#IgA#</a>, objectTitle=Lung Cancer：布加替尼（brigatinib）治疗既往治疗过的ALK+转移性非小细胞肺癌患者的疗效：真实世界研究, objectType=article, longId=213524, objectId=54582135246b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54582135246b, replyNumber=0, likeNumber=53, createdTime=2021-07-01, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54582135246b, moduleTitle=Lung Cancer：布加替尼（brigatinib）治疗既往治疗过的ALK+转移性非小细胞肺癌患者的疗效：真实世界研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54582135246b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IgA

2020-05-29

yibei (审核中...)

前往app查看评论内容

#IgA#

J Am Acad Dermatol：Omiganan可有效恢复轻中度特应性皮炎患者失调的菌群，但是不能改善患者的临床症状

2022-05-12

yibei (审核中...)

前往app查看评论内容

#IgA#

阿斯利康表示Farxiga达到了III期心力衰竭研究的主要终点

2022-05-11

yibei (审核中...)

前往app查看评论内容

#IgA#

FDA批准Igalmi治疗精神分裂症或双相障碍

2022-04-12

yibei (审核中...)

前往app查看评论内容

#IgA#

Kidney Int Rep：南亚前瞻性纵向观察IgA肾病队列的三年临床结果

2022-03-20

yibei (审核中...)

前往app查看评论内容

#IgA#

Front Med：C4d是狼疮性肾炎和IgA肾病临床结果的筛选工具和独立预测因子。

2022-03-20

yibei (审核中...)

前往app查看评论内容

#IgA#

20年来首个慢性肾脏病治疗药物Forxiga获得NICE推荐

2022-02-06

yibei (审核中...)

前往app查看评论内容

#IgA#

Front Immunol:313例捷克IgA肾病患者肾移植后的转归

2022-02-01

yibei (审核中...)

前往app查看评论内容

#IgA#

Front Immunol：IgA肾病风险预测模型比较的验证研究

2022-02-01

yibei (审核中...)

前往app查看评论内容

#IgA#

Front Immunol：高中性粒细胞与淋巴细胞比值是终末期IgA肾病的独立危险因素

2022-01-25

yibei (审核中...)

前往app查看评论内容

#IgA#

EBioMedicine：红细胞增多与IgA肾病有关

2022-01-19

yibei (审核中...)

前往app查看评论内容

#IgA#

Front Immunol：尿可溶性CD163水平可以预测IgA肾病缓解状态

2022-01-19

yibei (审核中...)

前往app查看评论内容

#IgA#

Sci Rep：静脉冲击注射甲基强的松龙联合小剂量强的松治疗高危IgA肾病

2022-01-18

yibei (审核中...)

前往app查看评论内容

#IgA#

因为知情同意不完善导致文章撤稿：老年肺转移腺癌患者的副肿瘤性IgA血管炎

2021-12-27

yibei (审核中...)

前往app查看评论内容

#IgA#

KIDNEY INT REP：牛津分类法在IgA肾病类固醇治疗中的应用

2021-10-24

yibei (审核中...)

前往app查看评论内容

#IgA#

J Thorac Oncol：Brigatinib（布加替尼）vs Crizotinib（克唑替尼）治疗未治ALK阳性晚期非小细胞肺癌患者的疗效：3期临床研究ALTA-1L最终分析结果

2021-09-20

yibei (审核中...)

前往app查看评论内容

#IgA#

NEJM: 李勇教授团队：FIGARO为糖尿病患者保肾护心再添利器

2021-09-01

yibei (审核中...)

前往app查看评论内容

#IgA#

Clin J Am Soc Nephrol：成人肾移植术后IgA肾病的复发情况如何？

2021-08-23

yibei (审核中...)

前往app查看评论内容

#IgA#

SGLT2抑制剂Forxiga获得欧盟和英国的批准，用于治疗慢性肾病

2021-08-11

智者为医08 (审核中...)

前往app查看评论内容

#IgA#

American Journal of Clinical Nutrition:益生菌治疗无法增加大便sIgA浓度

2021-07-30

智者为医08 (审核中...)

前往app查看评论内容

#IgA#

Lung Cancer：布加替尼（brigatinib）治疗既往治疗过的ALK+转移性非小细胞肺癌患者的疗效：真实世界研究

2021-07-01

科室
- - 订阅+
  - 更多科室
工具
服务